Offer - Urjas Oil for just ₹ 1
Rivasmine 1.5 Mg Capsule is a prescription medicine that is available as a Capsule. It is typically used for the treatment of Alzheimer's Disease, Parkinson's Disease. Rivasmine 1.5 Mg Capsule also has some secondary and off-label uses. These are listed below.
The optimal dosage of Rivasmine 1.5 Mg Capsule is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Rivasmine 1.5 Mg Capsule include Fainting, Indigestion. While these are the most often observed Rivasmine 1.5 Mg Capsule side effects, there are can be others also. These have been listed below. Usually, these side effects of Rivasmine 1.5 Mg Capsule go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Rivasmine 1.5 Mg Capsule has a Safe effect for pregnant women and Mild effect on lactating mothers. Warnings related to Rivasmine 1.5 Mg Capsule's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Kidney Disease, Asthma, COPD (Chronic Obstructive Pulmonary Disease) must refrain from the use of Rivasmine 1.5 Mg Capsule since this can cause severe adverse effects. Other conditions have been mentioned below in the Rivasmine 1.5 Mg Capsule contraindications section.
Drug interactions for Rivasmine 1.5 Mg Capsule have been reported in the medical literature. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Rivasmine 1.5 Mg Capsule is not safe while driving, and is is not addictive in nature.
Rivasmine 1.5 Mg Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Rivasmine 1.5 Mg Capsule safe for pregnant women?
Pregnant women can take Rivasmine safely.
Is the use of Rivasmine 1.5 Mg Capsule safe during breastfeeding?
Breastfeeding women can take Rivasmine as it bears very minor side effects for them.
What is the effect of Rivasmine 1.5 Mg Capsule on the Kidneys?
Rivasmine rarely harms the kidneys.
What is the effect of Rivasmine 1.5 Mg Capsule on the Liver?
Rivasmine may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Rivasmine 1.5 Mg Capsule on the Heart?
You can take Rivasmine without any fear of damage to the heart.
If you are suffering from any of the following diseases, you should not take Rivasmine 1.5 Mg Capsule unless your doctor advises you to do so -
Is this Rivasmine 1.5 Mg Capsule habit forming or addictive?
No, you will not get addicted to Rivasmine 1.5 Mg Capsule.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Rivasmine 1.5 Mg Capsule as you may feel sleepy.
Is it safe?
Rivasmine 1.5 Mg Capsule is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Yes, in many cases, taking Rivasmine 1.5 Mg Capsule can help with mental disorders.
Interaction between Food and Rivasmine 1.5 Mg Capsule
It is safe to take Rivasmine 1.5 Mg Capsule with food.
Interaction between Alcohol and Rivasmine 1.5 Mg Capsule
Consult your doctor before consuming alcohol while taking Rivasmine 1.5 Mg Capsule as it can have severe side effects.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Exelon® (rivastigmine tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 108
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1110-1112
